Provided by Tiger Fintech (Singapore) Pte. Ltd.

LIFECORE BIOMEDICAL INC

6.17
-0.1700-2.68%
Pre-market: 6.08-0.0900-1.46%07:16 EDT
Volume:79.55K
Turnover:495.25K
Market Cap:228.45M
PE:-4.14
High:6.40
Open:6.34
Low:6.15
Close:6.34
Loading ...

Company Profile

Company Name:
LIFECORE BIOMEDICAL INC
Exchange:
NASDAQ
Establishment Date:
1965
Employees:
524
Office Location:
3515 Lyman Boulevard,Chaska,Minnesota,United States
Zip Code:
55318
Fax:
- -
Introduction:
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Directors

Name
Position
Paul Josephs
President, Chief Executive Officer and Director
Katrina L. Houde
Director, Chairperson of the Board
Christopher Kiper
Director
Humberto C. Antunes
Director
Jason Aryeh
Director
Jeffrey L. Edwards
Director
Joshua E. Schechter
Director
Matthew Korenberg
Director
Nelson Obus
Director
Paul Johnson
Director
Raymond Diradoorian
Director

Shareholders

Name
Position
Paul Josephs
President, Chief Executive Officer and Director
John D. Morberg
Executive Vice-President, Chief Financial Officer and Secretary